0001193125-14-121728.txt : 20140328 0001193125-14-121728.hdr.sgml : 20140328 20140328170659 ACCESSION NUMBER: 0001193125-14-121728 CONFORMED SUBMISSION TYPE: 8-A12B PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20140328 DATE AS OF CHANGE: 20140328 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOLASE, INC CENTRAL INDEX KEY: 0000811240 STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843] IRS NUMBER: 870442441 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-A12B SEC ACT: 1934 Act SEC FILE NUMBER: 001-36385 FILM NUMBER: 14726673 BUSINESS ADDRESS: STREET 1: 4 CROMWELL CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-361-1200 MAIL ADDRESS: STREET 1: 4 CROMWELL CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: BIOLASE TECHNOLOGY INC DATE OF NAME CHANGE: 19941117 FORMER COMPANY: FORMER CONFORMED NAME: LASER MEDICAL TECHNOLOGY INC DATE OF NAME CHANGE: 19941117 FORMER COMPANY: FORMER CONFORMED NAME: LASER ENDO TECHNIC CORP DATE OF NAME CHANGE: 19920708 8-A12B 1 d703122d8a12b.htm 8-A12B 8-A12B

 

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-A

 

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR 12(g) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

 

Biolase, Inc.

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Delaware   87-0442441
(State of Incorporation or Organization)   (I.R.S. Employer Identification No.)
4 Cromwell, Irvine, California   92618
(Address of Principal Executive Offices)   (Zip Code)

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box.  x    If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective Pursuant to General Instruction A.(d), please check the following box.  ¨

Securities Act registration statement file number to which this form relates:                     

(If applicable)

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

to be so Registered

 

Name of Each Exchange on Which

Each Class is to be Registered

Rights to Purchase Preferred Stock   NASDAQ

 

 

Securities to be registered pursuant to Section 12(g) of the Act:

n/a

(Title of class)

 

 

 


Item 1. Description of Registrant’s Securities to be Registered.

On March 16, 2014, the Board of Directors (the “Board”) of Biolase, Inc. (the “Company”) approved an Amended and Restated Second Amendment, dated as of March 16, 2014 (the “Amendment”), to the Rights Agreement, dated as of December 31, 1998, as amended (the “Rights Agreement”), between the Company and Computershare Trust Company, N.A., successor to U.S. Stock Transfer Corporation, as rights agent (the “Rights Agreement”). The Amended and Restated Second Amendment was entered into in order to ensure the Company’s previously announced intention to change the triggering level of share ownership under the Rights Agreement from 15% to 20% of the Company’s Common Shares as of February 4, 2014 was unambiguously effected.

The rights issued pursuant to the Rights Agreement are in all respects subject to and governed by the provisions of the Rights Agreement, as amended. Copies of the Rights Agreement and the Amendment are available free of charge from the Company. The foregoing description of the Amendment is qualified in its entirety by reference to the full text of the Amendment, a copy of which is filed as an exhibit hereto and incorporated herein by this reference.

 

Item 2. Exhibits.

 

Exhibit
Number

  

Exhibit

4.1

   Amended and Restated Second Amendment to Rights Agreement, dated as of December 31, 1998, as amended, between the Company and Computershare Trust Company, N.A., successor to U.S. Stock Transfer Corporation, as rights agent.

 

2


SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

  BIOLASE, INC.
By:  

/s/ Federico Pignatelli

  Federico Pignatelli
  Chairman and Chief Executive Officer

Date: March 28, 2014

 

3


INDEX TO EXHIBITS

 

Exhibit

Number

  

Exhibit

4.1    Amended and Restated Second Amendment to Rights Agreement, dated as of December 31, 1998, as amended, between the Company and Computershare Trust Company, N.A., successor to U.S. Stock Transfer Corporation, as rights agent.

 

4

EX-4.1 2 d703122dex41.htm EX-4.1 EX-4.1

Exhibit 4.1

Annex A

AMENDED AND RESTATED SECOND AMENDMENT TO RIGHTS AGREEMENT

THIS AMENDED AND RESTATED SECOND AMENDMENT TO RIGHTS AGREEMENT (this “Restated Amendment”) is made and entered into as of March 17, 2014, by and between BIOLASE, INC., a Delaware corporation (the “Company”), and COMPUTERSHARE, TRUST COMPANY, N.A., as successor to U.S. Stock Transfer Corporation, a California corporation (the “Rights Agent”), and amends and restates in its entirety the Second Amendment to Rights Agreement, dated as of February 4, 2014, by and between the Company and the Rights Agent.

WHEREAS, the Company and the Rights Agent entered into a Rights Agreement dated as of December 31, 1998 (as amended, the “Agreement”); and

WHEREAS, for the avoidance of doubt with respect to the effectiveness of the Second Amendment to the Rights Agreement, dated as of February 4, 2014, in implementing the intended increase in the triggering level from 15% to 20%, the Company desires to further Amend and Restate the Second Amendment;

NOW, THEREFORE, for good consideration, the adequacy of which is hereby acknowledged, the Company hereby agrees to amend the Agreement as follows in accordance with the approval of the Board of the Directors as required by Section 27 thereof and directs the Rights Agent to execute the Restated Amendment:

1. Section 1 is hereby amended by replacing “15% Ownership Date” with “20% Ownership Date”. All references in the Agreement to “15% Ownership Date” shall be amended and replaced with “20% Ownership Date”.

2. Section 1 is hereby further amended by replacing “15% Stockholder” with “20% Stockholder”. All references in the Agreement to “15% Stockholder” shall be amended and replaced with “20% Stockholder”.

3. Section 1 is hereby further amended by replacing “15%” with “20%”. All references in the Agreement to “15%” shall be amended and replaced with “20%”.

4. Exhibit A to the Agreement is amended by replacing “15% Stockholder” with “20% Stockholder”. All references in Exhibit A to “15% Stockholder” shall be amended and replaced with “20% Stockholder”.

5. This Restated Amendment is effective as of February 4, 2014, the date of the Second Amendment.

Except as modified hereby, the Agreement is reaffirmed in all respects, and all references therein to “the Agreement” shall mean the Agreement, as modified hereby. Tgus

[Signature page follows]


IN WITNESS WHEREOF, the parties hereto have caused this Restated Amendment to be duly executed as of the date first written above.

 

BIOLASE, INC.
By:  

/s/ Frederico Pignatelli

Name:   Federico Pignatelli
Title:   Chairman and Chief Executive Officer
COMPUTERSHARE TRUST COMPANY, N.A.
By:  

/s/ Dennis Moccia

Name:   Dennis Moccia
Title:   Manager, Contract Administration